The first evidence for the inhibitory function of BTLA was demonstrated in mice deficient for this receptor, which showed an augmented risk of developing autoimmune diseases, such as encephalomyelitis and whose T lymphocytes displayed increased proliferative capacity as well [12, 19, 20]. The gene discussed is BTLA; the disease is autoimmune disease.